- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- May 2017
Comments
RED 1,2,3: NICE TA443 obeticholic acid is recommended for treating primary biliary cholangitis. (Decision date - May 2017)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again